Science News
from research organizations

Breakthrough improves method for synthesizing cyanohydrins as pharmaceutical precursors

February 22, 2016
Nagoya University
A new method of chemically modifying ketones has been developed in a way that ensures that optically active cyanohydrins are obtained, enabling efficient production of pharmaceutical precursors at a high yield and with good selectivity.

A cyano group is added to a ketone using a chiral lithium(I) catalyst system to achieve control over the symmetry of the resulting pharmaceutical cyanohydrins.
Credit: Nagoya University

In the production of pharmaceuticals, it is extremely important to produce molecules that have the right kind of symmetry. Even products that have the same composition, but are mirror images of each other, can have different effects in the body. Considerable interest has been generated by a recent advance made by scientists at Nagoya University, which was reported online in the journal Angewandte Chemie. Specifically, these researchers managed to modify molecules called ketones by adding new chemical groups in a way that produces more of a single mirror image of the same type of molecule.

This study extends previous work on modifying ketones to produce cyanohydrins, which are useful molecules because they are precursors of carboxylic acids and some amino acids, which are the building blocks of life. The similarity of cyanohydrins and their derivatives to amino acids means that they have important pharmaceutical properties. However, in previous studies, the modification of ketones to produce cyanohydrins was inefficient, time-consuming, could only produce a small amount of desired product, and was only available for a narrow range of compounds.

These obstacles have now been overcome by an innovative new reaction. "Using a new catalyst, chiral lithium(I) phosphoryl phenoxide, we have been able to add a cyano group with excellent enantioselectivity on ketones using lithium dicyanotrimethylsilicate(IV)," says Dr. Manabu Hatano, an associate professor and the first author. "This reaction had a high yield despite only a weak Lewis acid catalyst being used."

Previous studies in which efforts were made to produce optically active cyanohydrins encountered difficulties when using ketones rather than aldehydes as the molecules to be cyanosilylated because they are less reactive. This was overcome by the new approach, which was demonstrated by synthesizing a key intermediate for the production of (+)-13-hydroxyisocyclocelabenzine, a pharmaceutical that has antibacterial and antitumor effects.

"Another advantage of our new method is that the reaction time is much shorter, lasting only 2 to 9 hours rather than 1 to 2 days," according to Katsuya Yamakawa, another member of the research team. "This would be helpful in the pharmaceutical industry when attempting to produce the desired products on a large scale for medical use."

After the demonstration of this new catalytic system in a large-scale reaction, it is hoped that it can be applied widely for more effective cyanosilylation, enabling cheaper and more accurate production of pharmaceutical products.

Story Source:

Materials provided by Nagoya University. Note: Content may be edited for style and length.

Journal Reference:

  1. Manabu Hatano, Katsuya Yamakawa, Tomoaki Kawai, Takahiro Horibe, Kazuaki Ishihara. Enantioselective Cyanosilylation of Ketones with Lithium(I) Dicyanotrimethylsilicate(IV) Catalyzed by a Chiral Lithium(I) Phosphoryl Phenoxide. Angewandte Chemie International Edition, 2016; DOI: 10.1002/anie.201510682

Cite This Page:

Nagoya University. "Breakthrough improves method for synthesizing cyanohydrins as pharmaceutical precursors." ScienceDaily. ScienceDaily, 22 February 2016. <>.
Nagoya University. (2016, February 22). Breakthrough improves method for synthesizing cyanohydrins as pharmaceutical precursors. ScienceDaily. Retrieved May 23, 2017 from
Nagoya University. "Breakthrough improves method for synthesizing cyanohydrins as pharmaceutical precursors." ScienceDaily. (accessed May 23, 2017).